Top

Published in:

01-04-2012 | Valvular Heart Disease (V Nkomo, Section Editor)

Minimally Invasive Heart Valve Surgery: How and Why in 2012

Authors: Rakesh M. Suri, Nassir M. Thalji

Published in: Current Cardiology Reports | Issue 2/2012

Abstract

Cardiac surgical procedures via traditional sternotomy are safe and effective operations performed by cardiothoracic surgeons worldwide. However, postoperative limitations in upper extremity activity during bone healing are seen as undesirable by some. Percutaneous catheter-based attempts to emulate the outcomes of traditional cardiac surgical procedures have largely fallen short of established standards of efficacy and durability. The field of minimally invasive heart valve surgery thus developed out of a need to offer smaller, better-tolerated incisions to patients while maintaining high-quality clinical outcomes. These operations are safe and effective when performed by proficient surgical teams, allowing patients to resume normal activities more rapidly. We explore current evidence supporting the practice of minimally invasive heart valve surgery in 2012 and analyze the clinical impact of these nascent surgical platforms.

Adams DH, Carabello BA, Castillo J. Mitral Valve Regurgitation. In: Fuster V, Walsh RA, Harrington RA, editors. Hurst’s The Heart 13th ed, Chapter 77. New York: McGraw-Hill; 2011.

Nkomo VT, Gardin JM, Skelton TN, et al. Burden of valvular heart diseases: a population-based study. Lancet. 2006;368:1005–11.PubMedCrossRef

Carabello BA, Nakano K, Corin W, et al. Left ventricular function in experimental volume overload hypertrophy. Am J Physiol. 1989;256:H974–81.PubMed

Enriquez-Sarano M, Avierinos JF, Messika-Zeitoun D, et al. Quantitative determinants of the outcome of asymptomatic mitral regurgitation. N Engl J Med. 2005;352:875–83.PubMedCrossRef

Savage EB, Ferguson Jr TB, DiSesa VJ. Use of mitral valve repair: analysis of contemporary United States experience reported to the Society of Thoracic Surgeons National Cardiac Database. Ann Thorac Surg. 2003;75:820–5.PubMedCrossRef

Enriquez-Sarano M, Sundt III TM. Early surgery is recommended for mitral regurgitation. Circulation. 2010;121:804–11. discussion 12.PubMedCrossRef

• Bolling SF, Li S, O’Brien SM, et al. Predictors of mitral valve repair: clinical and surgeon factors. Ann Thorac Surg. 2010;90:1904–11. In a review of the STS ACSD, increased surgical center and surgeon-specific volumes of MV operations were associated with an increased proportion of MVRep instead of MVR. This is associated with improved quality of patient outcomes, and provides an argument in favor of specialist “heart-valve” teams and centers.PubMedCrossRef

Suri RM, Burkhart HM, Rehfeldt KH, et al. Robotic mitral valve repair for all categories of leaflet prolapse: improving patient appeal and advancing standard of care. Mayo Clin Proc. 2011;86:838–44.PubMedCrossRef

Suri RM, Schaff HV, Dearani JA, et al. Recurrent mitral regurgitation after repair: should the mitral valve be re-repaired? J Thorac Cardiovasc Surg. 2006;132:1390–7.PubMedCrossRef

10.

Suri RM, Schaff HV, Dearani JA, et al. Survival advantage and improved durability of mitral repair for leaflet prolapse subsets in the current era. Ann Thorac Surg. 2006;82:819–26.PubMedCrossRef

11.

Suri RM, Schaff HV, Dearani JA, et al. Recovery of left ventricular function after surgical correction of mitral regurgitation caused by leaflet prolapse. J Thorac Cardiovasc Surg. 2009;137:1071–6.PubMedCrossRef

12.

Suri RM, Schaff HV, Dearani JA, et al. Determinants of early decline in ejection fraction after surgical correction of mitral regurgitation. J Thorac Cardiovasc Surg. 2008;136:442–7.PubMedCrossRef

13.

Enriquez-Sarano M, Tajik AJ, Schaff HV, et al. Echocardiographic prediction of survival after surgical correction of organic mitral regurgitation. Circulation. 1994;90:830–7.PubMed

14.

Tribouilloy CM, Enriquez-Sarano M, Schaff HV, et al. Impact of preoperative symptoms on survival after surgical correction of organic mitral regurgitation: rationale for optimizing surgical indications. Circulation. 1999;99:400–5.PubMed

15.

Bonow RO, Carabello BA, Chatterjee K, et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing Committee to Revise the 1998 guidelines for the management of patients with valvular heart disease) developed in collaboration with the Society of Cardiovascular Anesthesiologists endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. J Am Coll Cardiol. 2006;48:e1–148.PubMedCrossRef

16.

Leon MB, Smith CR, Mack M, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010;363:1597–607.PubMedCrossRef

17.

Alfieri O, Maisano F, De Bonis M, et al. The double-orifice technique in mitral valve repair: a simple solution for complex problems. J Thorac Cardiovasc Surg. 2001;122:674–81.PubMedCrossRef

18.

Fann JI, St Goar FG, J Komtebedde, et al. Beating heart catheter-based edge-to-edge mitral valve procedure in a porcine model: efficacy and healing response. Circulation. 2004;110:988–93.PubMedCrossRef

19.

Feldman T, Foster E, Glower DD, et al. Percutaneous repair or surgery for mitral regurgitation. N Engl J Med. 2011;364:1395–406.PubMedCrossRef

20.

• McClure RS, Cohn LH, Wiegerinck E, et al. Early and late outcomes in minimally invasive mitral valve repair: an eleven-year experience in 707 patients. J Thorac Cardiovasc Surg. 2009;137:70–5. In this review of 707 patients undergoing minimally invasive MVRep at a single institution, evidence is provided supporting the safety and long-term durability of minimally invasive techniques for MVRep.PubMedCrossRef

21.

Cohn LH, Adams DH, Couper GS, et al. Minimally invasive cardiac valve surgery improves patient satisfaction while reducing costs of cardiac valve replacement and repair. Ann Surg. 1997;226:421–6. discussion 7–8.PubMedCrossRef

22.

Navia JL, Cosgrove 3rd DM. Minimally invasive mitral valve operations. Ann Thorac Surg. 1996;62:1542–4.PubMedCrossRef

23.

Carpentier A, Loulmet D, Le Bret E, et al. Open heart operation under videosurgery and minithoracotomy. First case (mitral valvuloplasty) operated with success. C R Acad Sci III. 1996;319:219–23.PubMed

24.

Falk V, Walther T, Autschbach R, et al. Robot-assisted minimally invasive solo mitral valve operation. J Thorac Cardiovasc Surg. 1998;115:470–1.PubMedCrossRef

25.

Carpentier A, Loulmet D, Aupecle B, et al. Computer assisted open heart surgery. First case operated on with success. C R Acad Sci III. 1998;321:437–42.PubMed

26.

Chitwood Jr WR, Nifong LW, Elbeery JE, et al. Robotic mitral valve repair: trapezoidal resection and prosthetic annuloplasty with the da vinci surgical system. J Thorac Cardiovasc Surg. 2000;120:1171–2.PubMedCrossRef

27.

Chitwood Jr WR. Current status of endoscopic and robotic mitral valve surgery. Ann Thorac Surg. 2005;79:S2248–53.PubMedCrossRef

28.

Chitwood Jr WR, Rodriguez E, Chu MW, et al. Robotic mitral valve repairs in 300 patients: a single-center experience. J Thorac Cardiovasc Surg. 2008;136:436–41.PubMedCrossRef

29.

Murphy DA, Miller JS, Langford DA, Snyder AB. Endoscopic robotic mitral valve surgery. J Thorac Cardiovasc Surg. 2006;132:776–81.PubMedCrossRef

30.

Schmitto JD, Mokashi SA, Cohn LH. Minimally-invasive valve surgery. J Am Coll Cardiol. 2010;56:455–62.PubMedCrossRef

31.

•• Suri RM, Burkhart HM, Daly RC, et al. Robotic mitral valve repair for all prolapse subsets using techniques identical to open valvuloplasty: Establishing the benchmark against which percutaneous interventions should be judged. J Thorac Cardiovasc Surg. 2011;142:970–9. This is a propensity-matched analysis of outcomes following robot-assisted versus open MVRep for all subsets of MV leaflet prolapse. Robotic technology permits performance of safe and effective operative repair duplicating open transsternal operations. This study depicts the team-based learning curve associated with the adoption of robotic technlogy.PubMedCrossRef

32.

• Gammie JS, Zhao Y, Peterson ED, et al. J. Maxwell Chamberlain Memorial Paper for adult cardiac surgery. Less-invasive mitral valve operations: trends and outcomes from the Society of Thoracic Surgeons Adult Cardiac Surgery Database. Ann Thorac Surg. 2010;90:1401–8. 10 e1 discussion 8–10. This is a review STS ACSD outlining the trends of minimally invasive MV surgery over the last decade. The incidence of minimally invasive procedures has doubled from 11.9% of cases in 2004 to 20.1% of cases in 2008. However, there remains a significant capacity for wider dissemination of minimally invasive approaches to MV surgery.PubMedCrossRef

33.

Svensson LG, Atik FA, Cosgrove DM, et al. Minimally invasive versus conventional mitral valve surgery: a propensity-matched comparison. J Thorac Cardiovasc Surg. 2010;139:926–32. e1–2.PubMedCrossRef

34.

Suri RM, Schaff HV, Meyer SR, Hargrove 3rd WC. Thoracoscopic versus open mitral valve repair: a propensity score analysis of early outcomes. Ann Thorac Surg. 2009;88:1185–90.PubMedCrossRef

35.

Modi P, Hassan A, Chitwood Jr WR. Minimally invasive mitral valve surgery: a systematic review and meta-analysis. Eur J Cardiothorac Surg. 2008;34:943–52.PubMedCrossRef

36.

Grossi EA, Galloway AC, Ribakove GH, et al. Minimally invasive port access surgery reduces operative morbidity for valve replacement in the elderly. Heart Surg Forum. 1999;2:212–5.PubMed

37.

Santana O, Reyna J, Grana R, et al. Outcomes of minimally invasive valve surgery versus standard sternotomy in obese patients undergoing isolated valve surgery. Ann Thorac Surg. 2011;91:406–10.PubMedCrossRef

38.

Grossi EA, Galloway AC, Ribakove GH, et al. Impact of minimally invasive valvular heart surgery: a case-control study. Ann Thorac Surg. 2001;71:807–10.PubMedCrossRef

39.

Murphy GJ, Reeves BC, Rogers CA, et al. Increased mortality, postoperative morbidity, and cost after red blood cell transfusion in patients having cardiac surgery. Circulation. 2007;116:2544–52.PubMedCrossRef

40.

Stokes ME, Ye X, Shah M, et al. Impact of bleeding-related complications and/or blood product transfusions on hospital costs in inpatient surgical patients. BMC Health Serv Res. 2011;11:135.PubMedCrossRef

41.

Mihaljevic T, Cohn LH, Unic D, et al. One thousand minimally invasive valve operations: early and late results. Ann Surg. 2004;240:529–34.PubMedCrossRef

42.

Lamelas J, Sarria A, Santana O, et al. Outcomes of minimally invasive valve surgery versus median sternotomy in patients age 75 years or greater. Ann Thorac Surg. 2011;91:79–84.PubMedCrossRef

43.

Schmitto JD, Mohr FW, Cohn LH. Minimally invasive aortic valve replacement: how does this perform in high-risk patients? Curr Opin Cardiol. 2011;26:118–22.PubMedCrossRef

44.

Casselman FP, Van Slycke S, Dom H, et al. Endoscopic mitral valve repair: feasible, reproducible, and durable. J Thorac Cardiovasc Surg. 2003;125:273–82.PubMedCrossRef

45.

Vleissis AA, Bolling SF. Mini-reoperative mitral valve surgery. J Card Surg. 1998;13:468–70.PubMedCrossRef

46.

Chitwood Jr WR, Wixon CL, Elbeery JR, et al. Video-assisted minimally invasive mitral valve surgery. J Thorac Cardiovasc Surg. 1997;114:773–80. discussion 80–2.PubMedCrossRef

47.

Cosgrove 3rd DM, Sabik JF, Navia JL. Minimally invasive valve operations. Ann Thorac Surg. 1998;65:1535–8. discussion 8–9.PubMedCrossRef

48.

• Iribarne A, Easterwood R, Russo MJ, et al. A minimally invasive approach is more cost-effective than a traditional sternotomy approach for mitral valve surgery. J Thorac Cardiovasc Surg. 2011;142(6):1507–14. This is an in-depth economic analysis of minimally invasive versus traditional sternotomy approaches for MV surgery revealing that minimally invasive techniques are both cost-effective and cost-saving.PubMedCrossRef

49.

Felger JE, Nifong LW, Chitwood Jr WR. The evolution of and early experience with robot-assisted mitral valve surgery. Surg Laparosc Endosc Percutan Tech. 2002;12:58–63.PubMedCrossRef

50.

Mihaljevic T, Jarrett CM, Gillinov AM, et al. Robotic repair of posterior mitral valve prolapse versus conventional approaches: potential realized. J Thorac Cardiovasc Surg. 2011;141:72–80. e1-4.PubMedCrossRef

51.

Cheng W, Fontana GP, De Robertis MA, et al. Is robotic mitral valve repair a reproducible approach? J Thorac Cardiovasc Surg. 2010;139:628–33.PubMedCrossRef

52.

Freeman RV, Otto CM. Aortic Valve Disease. In: Fuster V, Walsh RA, Harrington RA, editors. Hurst’s The Heart 13th ed, Chapter 76. New York: McGraw-Hill; 2011.

53.

Shekar PS, Cohn LH. Minimally Invasive Aortic Valve Surgery. In: Cohn LH, editor. Cardiac Surgery in the Adult 3 rd ed, Chapter 39. New York: McGraw-Hill; 2008. p. 957–64.

54.

Cosgrove 3rd DM, Sabik JF. Minimally invasive approach for aortic valve operations. Ann Thorac Surg. 1996;62:596–7.PubMedCrossRef

55.

Gillinov AM, Banbury MK, Cosgrove DM. Hemisternotomy approach for aortic and mitral valve surgery. J Card Surg. 2000;15:15–20.PubMedCrossRef

56.

Brown ML, McKellar SH, Sundt TM, Schaff HV. Ministernotomy versus conventional sternotomy for aortic valve replacement: a systematic review and meta-analysis. J Thorac Cardiovasc Surg. 2009;137:670–9.PubMedCrossRef

57.

Byrne JG, Aranki SF, Couper GS, et al. Reoperative aortic valve replacement: partial upper hemisternotomy versus conventional full sternotomy. J Thorac Cardiovasc Surg. 1999;118:991–7.PubMedCrossRef

58.

ElBardissi AW, Shekar P, Couper GS, Cohn LH. Minimally invasive aortic valve replacement in octogenarian, high-risk, transcatheter aortic valve implantation candidates. J Thorac Cardiovasc Surg. 2011;141:328–35.PubMedCrossRef

59.

Smith CR, Leon MB, Mack MJ, et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med. 2011;364:2187–98.PubMedCrossRef

60.

Flameng W, Herregods MC, Hermans H, et al. Effect of sutureless implantation of the Perceval S aortic valve bioprosthesis on intraoperative and early postoperative outcomes. J Thorac Cardiovasc Surg. 2011;142(6):1453–7.PubMedCrossRef

61.

Martens S, Sadowski J, Eckstein FS, et al. Clinical experience with the ATS 3f Enable(R) Sutureless Bioprosthesis. Eur J Cardiothorac Surg. 2011;40:749–55.PubMed

62.

Suri RM, Burkhart HM, Schaff HV. Robot-assisted aortic valve replacement using a novel sutureless bovine pericardial prosthesis: proof of concept as an alternative to percutaneous implantation. Innovations. 2010;5:419–23.

63.

Bach DS, Awais M, Gurm HS, Kohnstamm S. Failure of guideline adherence for intervention in patients with severe mitral regurgitation. J Am Coll Cardiol. 2009;54:860–5.PubMedCrossRef

64.

Toledano K, Rudski LG, Huynh T, et al. Mitral regurgitation: determinants of referral for cardiac surgery by Canadian cardiologists. Can J Cardiol. 2007;23:209–14.PubMedCrossRef

65.

Lee TH, Hillis LD, Nabel EG. CABG vs. stenting–clinical implications of the SYNTAX trial. N Engl J Med. 2009;360:e10.PubMedCrossRef

66.

Michelena HI, Abel MD, Suri RM, et al. Intraoperative echocardiography in valvular heart disease: an evidence-based appraisal. Mayo Clin Proc. 2010;85:646–55.PubMedCrossRef

67.

Rehfeldt KH, Mauermann WJ, Burkhart HM, Suri RM. Robot-assisted mitral valve repair. J Cardiothorac Vasc Anesth. 2011;25:721–30.PubMedCrossRef

Title: Minimally Invasive Heart Valve Surgery: How and Why in 2012
Authors: Rakesh M. Suri
Nassir M. Thalji
Publication date: 01-04-2012
Publisher: Current Science Inc.
Published in: Current Cardiology Reports / Issue 2/2012
Print ISSN: 1523-3782
Electronic ISSN: 1534-3170
DOI: https://doi.org/10.1007/s11886-011-0244-8

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Minimally Invasive Heart Valve Surgery: How and Why in 2012

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 2/2012

The Potential Utility of 123I-mIBG in Atrial Fibrillation and in the Electrophysiology Laboratory

Tricuspid Regurgitation: Pathophysiology and Management

Ischemic Mitral Regurgitation: Not Only a Bystander

Carotid Artery Stenting Versus Carotid Endarterectomy: Post CREST

Current Endovascular Management of Abdominal Aortic Aneurysm

Management of Combined Severe Carotid and Coronary Artery Disease

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page